The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
90 jobs Number of planned job losses
Announcement Date
15 June 2007
Employment effect (start)
1 August 2007
Foreseen end date
1 March 2008
Description
90 jobs could go at a pharmaceuticals factory in Wrexham, it has been announced. Wockhardt UK, which employs 395 staff, has blamed the proposal on competition from rival manufacturers in Germany, Eastern Europe and Asia. About half of the threatened jobs, mainly in manufacturing, could go in August, and the rest in March 2008. However, the company said its sterile manufacturing operations were likely to grow over the next three years. The Indian firm now plans to hold talks with trade unions and workers' representatives on the proposals, which include the phased closure of tablet manufacture and packing departments, and the 'downsizing' of the liquids section. The company, which is on the Wrexham industrial estate, makes drugs, including natural insulins and herapin, for a variety of customers. The company said no final decision would be taken on the proposals until these consultations had taken place. A spokesperson added: 'While we regret the need to consider this action, various external factors have made it inevitable in order to maintain Wockhardt's UK operations as a strong and sustainable organisation in the long term.'
'We would like to emphasise that in no way does this action lessen our respect for and appreciation of the quality of our workforce.'
The company said around 300 staff would be safe from redundancy and employee numbers in its sterile facility had already increased from 64 to 90 in the last 15 months. It also said the company had invested 5.4million GBP in the previous four years to upgrade its manufacturing facilities.
Sources
15 June 2007: BBC News
Citation
Eurofound (2007), Wockhardt, Internal restructuring in United Kingdom, factsheet number 65497, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/65497.
Eurofound’s ERM restructuring legislation database offers an overview of key restructuring-related regulations in the EU Member States and Norway. Its content is continuously updated to reflect any changes made by national legislators in response to, for instance, policy shifts, legal...
Can Europe still achieve its ambitions for battery manufacturing? To answer this, the article looks at data from Eurofound’s European Restructuring Monitor and explores what recent large-scale restructuring events reveal about the state of play in the EU battery sector.
This working paper offers a comprehensive methodological overview of the European Restructuring Monitor (ERM) databases. Even though the methodology has not changed over time, new categories have been added, and the way it has been used by researchers and policymakers...
This Eurofound research paper explores key trends in restructuring in recent years, highlighting the companies that announced the largest job losses and job gains in the EU. It builds on an analysis of company announcements recorded in Eurofound’s European Restructuring...
In 2023, thousands of workers in big tech lost their jobs. Meta, Amazon, Google, Apple, Microsoft and Salesforce had been considered to offer good and secure jobs up to this point. Giants of the information and communication technology (ICT) sector,...
In 2024, the automotive sector in the EU came to the fore in public and policy discussions. The focus was on the slowdown in electric vehicle (EV) sales, rising global competition, belated investments in new technologies, and the potential closure...